- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Sequent Scientific Limited — Updates, 18-11-2025: Press Release
18-11-2025 | 11:05 pm
18-11-2025 | 11:05 pm
SeQuent & Viyash merger received NCLT approval. Combined Q2 sales rose 16% to ₹852.1 Cr, EBITDA surged 76% to ₹189.0 Cr. H1 revenue hit ₹1646.2 Cr, EBITDA ₹318.0 Cr. The merger creates a global animal health powerhouse.
No comments yet. Be the first to comment!